Lv1
26 积分 2024-03-08 加入
Transcriptomic Heterogeneity of EGFR -Mutant Non–Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer
11天前
已完结
EGFR- and HER3-targeted bispecific antibody-drug conjugate demonstrates anti-tumor activity in metastatic castration-resistant prostate cancer
15天前
已完结
HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis
15天前
已完结
HER3-targeted therapy: the mechanism of drug resistance and the development of anticancer drugs
17天前
已完结
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer
17天前
已完结
HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis
18天前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
19天前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
22天前
已完结
Structure-based classification predicts drug response in EGFR-mutant NSCLC
25天前
已完结
Emerging importance of HER3 in tumorigenesis and cancer therapy
27天前
已完结
皖公网安备34019202002308
